SK Biopharm, Hanmi sign deal to sell epilepsy drug
IndustryApr 22, 2012
SK Biopharmaceuticals Co. said Sunday it established a strategic partnership with Hanmi Pharm Co. to sell a nasal spray-type epilepsy drug in Korea and China.Hanmi and its Chinese arm will get the approval for sales and handle marketing in Korea and China, under the partnership. The diazepam nasal spray quickly transfers the diazepam substance to the brain through the mucous membranes inside the nasal cavity, allowing swift treatment, according to SK Biopharm.The pharmaceutical company expects t